Login / Signup

Survey on patients' organisations' knowledge and position paper on screening for inherited neuromuscular diseases in Europe.

F LamyA Ferlininull nullTeresinha Evangelista
Published in: Orphanet journal of rare diseases (2021)
This is the first study to assess knowledge and needs of POs concerning screening for NMDs. The knowledge of POs regarding screening techniques is quite uneven. This implies that, even in communities highly motivated and knowledgeable of the conditions they advocate for, there is a need for better information. Differences in the responses to the questions "how and when to screen" shows that the screening path depends on the disease and the presence of a disease modifying treatment. The unmet need for screening inherited NMDs should follow an adaptive pathway related to the fast moving medical landscape of NMDs. International coordination leading to a common policy would certainly be a precious asset tending to harmonize the situation amongst European countries.
Keyphrases
  • healthcare
  • newly diagnosed
  • end stage renal disease
  • ejection fraction
  • mental health
  • public health
  • cross sectional
  • high throughput
  • combination therapy
  • smoking cessation
  • replacement therapy